U.S. Oncology Companion Diagnostic Market Size & Outlook

Name: U.S. Oncology Companion Diagnostic Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The oncology companion diagnostic market in the United States is expected to reach a projected revenue of US$ 2,591.3 million by 2030. A compound annual growth rate of 7.1% is expected of the United States oncology companion diagnostic market from 2024 to 2030.

Clinical Diagnostics
- In Vitro Diagnostics
  - oncology companion diagnostics market

U.S. oncology companion diagnostics product & service outlook (Revenue, USD million, 2018-2030)
- Product
  - Instrument
  - Consumables
  - Software
- Service
U.S. oncology companion diagnostics end use outlook (Revenue, USD million, 2018-2030)
- Hospital
- Pathology/Diagnostic laboratory
- Academic medical center
U.S. oncology companion diagnostics disease type outlook (Revenue, USD million, 2018-2030)
- Breast cancer
- Non-small cell lung cancer
- Colorectal cancer
- Leukemia
- Melanoma
- Prostate cancer
- Others
U.S. oncology companion diagnostics technology outlook (Revenue, USD million, 2018-2030)
- Polymerase chain reaction (PCR)
- Next-generation sequencing (NGS)
- Immunohistochemistry (IHC)
- In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
- Other technologies

U.S. Oncology Companion Diagnostic Market Size & Outlook

Data Tree

Sign up - it's easy, and free!